TAK
Takeda Pharmaceutical
$17.44
+$0.20 (+1.16%)Jul 27, 2026
Key metrics
The numbers that frame TAK today
- Market cap
- $55.10B
- P/E (TTM)
- -57.9
- EV / FCF
- 15.9
- Gross margin
- 65.1%
- EV / Sales
- 3.1
- ROIC
- 2.6%
- Div yield
- 1.85%
- Debt / equity
- 0.8
- 52wk Low
- $12.99
- 52wk High
- $18.90
Growth
Revenue and earnings trend for TAK
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TAK
Is Takeda Pharmaceutical a good buy?
Hold. Takeda Pharmaceutical has strong quality and mixed momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Takeda Pharmaceutical is selling at a fair price.
What is the market capitalization of TAK?
Takeda Pharmaceutical's market capitalization is $55.10B.
What is the P/E ratio for TAK stock?
Takeda Pharmaceutical's current P/E ratio is -57.9.
What is the 52-week high for TAK stock?
The 52-week high for Takeda Pharmaceutical is $18.90. The current close of $17.44 is 7.7% below that high.
What is the 52-week low for TAK stock?
The 52-week low for Takeda Pharmaceutical is $12.99. The current close of $17.44 is 34.3% above that low.
Does TAK stock pay dividends?
Takeda Pharmaceutical pays a dividend. The latest dividend per share in the company data is $0.32, which implies a yield of 1.85% based on the current close.
What is the Debt / Equity ratio for TAK?
Takeda Pharmaceutical's Debt / Equity ratio is 0.75.